Biosimilars Market Analysis: Expanding Access to High-Value Biologics and Reducing Healthcare Costs
Biosimilars—highly similar versions of already approved biological drugs—are transforming the pharmaceutical landscape by providing more affordable alternatives to expensive "blockbuster" biologics. As patents on many original biologics expire, the market for these follow-on products is expanding rapidly. Use cases for biosimilars include the treatment of chronic conditions like...
0 Commenti 0 condivisioni 76 Views 0 Anteprima